US Edition
Published • loading... • Updated
Novo Nordisk A/S (NYSE:NVO) Trading Down 2.9% - Time to Sell?
Summary by marketbeat.com
2 Articles
2 Articles
Why I'm Not Worried About Novo Nordisk Stock
Key PointsInvestors have been dumping shares of Novo Nordisk amid concerns it can't keep up with Eli Lilly.Novo Nordisk is expecting sales to decline this year, potentially by double digits.The stock's valuation looks incredibly low, trading at a price-to-earnings multiple of just 10.10 stocks we like better than Novo Nordisk › Novo Nordisk (NYSE: NVO) stock has been a trainwreck of late. In just the past 12 months, the Danish healthcare stock h…
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
